CARLOS BRAVO PEREZ

Fernández-Pérez MP, Águila S, Reguilón-Gallego L, de Los Reyes-García AM, Miñano A, Bravo-Pérez C, de la Morena ME, Corral J, García-Barberá N, Gómez-Verdú JM, Bernal E, Herranz MT, Vicente V, Martínez C, González-Conejero R, Lozano ML. Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes. Clin Transl Med. 2021 Jan;11(1):e268. doi: 10.1002/ctm2.268. PubMed PMID: 33463053; PubMed Central PMCID: PMC7775985.

AÑO: 2021; IF: 8.554

33463053

Bravo-Pérez C, de la Morena-Barrio ME, Vicente V, Corral J. Antithrombin deficiency as a still underdiagnosed thrombophilia: a primer for internists. Pol Arch Intern Med. 2020 Oct 29;130(10):868-877. doi: 10.20452/pamw.15371. Epub 2020 May 19. PubMed PMID: 32426958.

AÑO: 2020; IF: 3.277

32426958

Bravo-Pérez C, Sola M, Teruel-Montoya R, García-Malo MD, Ortuño FJ, Vicente V, de Arriba F, Jerez A. Minimal Residual Disease in Multiple Myeloma: Something Old, Something New. Cancers (Basel). 2021 Aug 27;13(17). pii: 4332. doi: 10.3390/cancers13174332. Review. PubMed PMID: 34503142; PubMed Central PMCID: PMC8430644.

AÑO: 2021; IF: 6.575

34503142

Bravo-Perez C, García-Torralba E, Lopez-Poveda MJ, Ortuño FJ. CD56- and CD117-positive neuroendocrine neoplasm presenting with leukemic phase and bone marrow infiltration mimicking acute leukemia. Int J Lab Hematol. 2021 Aug;43(4):536-537. doi: 10.1111/ijlh.13578. Epub 2021 Jun 4. PubMed PMID: 34086417.

AÑO: 2021; IF: 3.45

34086417

Bravo-Perez C, Fernández-Caballero M, Soler-Espejo E, Garcia-Torralba E, Sorigue M, García-Malo MD, Jerez A, Vicente V, Roldán V, de Arriba F. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma. J Thromb Thrombolysis. 2021 Oct;52(3):848-853. doi: 10.1007/s11239-021-02407-5. Epub 2021 Mar 1. PubMed PMID: 33649980.

AÑO: 2021; IF: 5.221

33649980